Logo image of LNTH

LANTHEUS HOLDINGS INC (LNTH) Stock Price, Quote, News and Overview

NASDAQ:LNTH - Nasdaq - US5165441032 - Common Stock - Currency: USD

75.56  +0.04 (+0.05%)

After market: 75.56 0 (0%)

LNTH Quote, Performance and Key Statistics

LANTHEUS HOLDINGS INC

NASDAQ:LNTH (5/30/2025, 8:00:00 PM)

After market: 75.56 0 (0%)

75.56

+0.04 (+0.05%)

Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Supplies
Statistics
52 Week High126.89
52 Week Low73.11
Market Cap5.23B
Shares69.19M
Float67.53M
Yearly DividendN/A
Dividend YieldN/A
PE11.41
Fwd PE10
Earnings (Next)07-29 2025-07-29/bmo
IPO06-25 2015-06-25


LNTH short term performance overview.The bars show the price performance of LNTH in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 -5 -10 -15 -20 -25

LNTH long term performance overview.The bars show the price performance of LNTH in the last 1, 2 and 3 years. 1 year 2 years 3 years 0 5 -5 10 -10

The current stock price of LNTH is 75.56 USD. In the past month the price decreased by -28.66%. In the past year, price decreased by -7.66%.

LANTHEUS HOLDINGS INC / LNTH Daily stock chart

LNTH Competitors/Peers

The largest stocks on the US markets in the "Health Care Supplies" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
ALC ALCON INC 28.65 42.94B
COO COOPER COS INC/THE 17.6 13.65B
ALGN ALIGN TECHNOLOGY INC 19.39 13.11B
SOLV SOLVENTUM CORP 12.28 12.65B
MMSI MERIT MEDICAL SYSTEMS INC 26.62 5.62B
BLCO BAUSCH + LOMB CORP 23.9 4.05B
ICUI ICU MEDICAL INC 19.32 3.32B
HAE HAEMONETICS CORP/MASS 14.82 3.25B
XRAY DENTSPLY SIRONA INC 9.51 3.18B
UFPT UFP TECHNOLOGIES INC 28.67 1.81B
NEOG NEOGEN CORP 15.42 1.27B
ESTA ESTABLISHMENT LABS HOLDINGS N/A 995.43M

About LNTH

Company Profile

LNTH logo image Lantheus Holdings, Inc. engages in the provision of diagnostic imaging and nuclear medicine products. The company is headquartered in North Billerica, Massachusetts and currently employs 808 full-time employees. The company went IPO on 2015-06-25. The company classifies its products in three categories: Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships. Radiopharmaceutical Oncology diagnostics and therapeutics help healthcare professionals (HCPs) find, fight and follow cancer, with a focus on prostate cancer. Precision Diagnostic products assist HCPs to find and follow diseases, with a focus on cardiology. Strategic Partnerships focus on enabling precision medicine through the use of biomarker solutions, digital solutions, and radiotherapeutic platforms. Its commercial products include PYLARIFY, DEFINITY, TechneLite, and others. Its clinical candidates include LNTH-2404, NAV-4694, and PNT2002, others. Its OCTEVY is a registrational-stage positron emission tomography (PET) diagnostic imaging agent targeting neuroendocrine tumors.

Company Info

LANTHEUS HOLDINGS INC

331 Treble Cove Rd

North Billerica MASSACHUSETTS 01862 US

CEO: Mary Anne Heino

Employees: 808

LNTH Company Website

LNTH Investor Relations

Phone: 19786718001

LANTHEUS HOLDINGS INC / LNTH FAQ

What is the stock price of LANTHEUS HOLDINGS INC today?

The current stock price of LNTH is 75.56 USD. The price increased by 0.05% in the last trading session.


What is the ticker symbol for LANTHEUS HOLDINGS INC stock?

The exchange symbol of LANTHEUS HOLDINGS INC is LNTH and it is listed on the Nasdaq exchange.


On which exchange is LNTH stock listed?

LNTH stock is listed on the Nasdaq exchange.


What is the price forecast or stock price prediction for LANTHEUS HOLDINGS INC stock?

19 analysts have analysed LNTH and the average price target is 137.62 USD. This implies a price increase of 82.14% is expected in the next year compared to the current price of 75.56. Check the LANTHEUS HOLDINGS INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is LANTHEUS HOLDINGS INC worth?

LANTHEUS HOLDINGS INC (LNTH) has a market capitalization of 5.23B USD. This makes LNTH a Mid Cap stock.


How many employees does LANTHEUS HOLDINGS INC have?

LANTHEUS HOLDINGS INC (LNTH) currently has 808 employees.


What are the support and resistance levels for LANTHEUS HOLDINGS INC (LNTH) stock?

LANTHEUS HOLDINGS INC (LNTH) has a support level at 73.86 and a resistance level at 81.24. Check the full technical report for a detailed analysis of LNTH support and resistance levels.


Is LANTHEUS HOLDINGS INC (LNTH) expected to grow?

The Revenue of LANTHEUS HOLDINGS INC (LNTH) is expected to grow by 3.55% in the next year. Check the estimates tab for more information on the LNTH EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy LANTHEUS HOLDINGS INC (LNTH) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does LANTHEUS HOLDINGS INC (LNTH) stock pay dividends?

LNTH does not pay a dividend.


When does LANTHEUS HOLDINGS INC (LNTH) report earnings?

LANTHEUS HOLDINGS INC (LNTH) will report earnings on 2025-07-29, before the market open.


What is the Price/Earnings (PE) ratio of LANTHEUS HOLDINGS INC (LNTH)?

The PE ratio for LANTHEUS HOLDINGS INC (LNTH) is 11.41. This is based on the reported non-GAAP earnings per share of 6.62 and the current share price of 75.56 USD. Check the full fundamental report for a full analysis of the valuation metrics for LNTH.


What is the Short Interest ratio of LANTHEUS HOLDINGS INC (LNTH) stock?

The outstanding short interest for LANTHEUS HOLDINGS INC (LNTH) is 10.33% of its float. Check the ownership tab for more information on the LNTH short interest.


LNTH Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

LNTH Fundamental Analysis

ChartMill assigns a fundamental rating of 8 / 10 to LNTH. Both the health and profitability get an excellent rating, making LNTH a very profitable company, without any liquidiy or solvency issues.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

LNTH Financial Highlights

Over the last trailing twelve months LNTH reported a non-GAAP Earnings per Share(EPS) of 6.62. The EPS increased by 2.64% compared to the year before.


Industry RankSector Rank
PM (TTM) 16.55%
ROA 12.37%
ROE 21.85%
Debt/Equity 0.49
Chartmill High Growth Momentum
EPS Q2Q%-9.47%
Sales Q2Q%0.75%
EPS 1Y (TTM)2.64%
Revenue 1Y (TTM)12.53%

LNTH Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 82% to LNTH. The Buy consensus is the average rating of analysts ratings from 19 analysts.

For the next year, analysts expect an EPS growth of 0.63% and a revenue growth 3.55% for LNTH


Ownership
Inst Owners110.89%
Ins Owners1.47%
Short Float %10.33%
Short Ratio6.52
Analysts
Analysts82.11
Price Target137.62 (82.13%)
EPS Next Y0.63%
Revenue Next Year3.55%